Phase II study of amrubicin for previously treated advanced non-small cell lung cancer.
Latest Information Update: 15 Aug 2015
At a glance
- Drugs Amrubicin (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
Most Recent Events
- 05 Mar 2009 New trial record.